BeyondSpring (BYSI) Research & Development (2016 - 2026)
BeyondSpring (BYSI) recorded Research & Development of $973,000 in Q2 2026, down 2.9% from $1 million a year earlier and down 9.6% from the prior quarter.
BeyondSpring (BYSI) Research & Development (2016 - 2026) Analysis & Trends
On a TTM basis, BeyondSpring's Research & Development came in at $4.56 million as of Jun 30, 2026, up 53.6% year-over-year; for FY2025, it was $4.39 million, up 66.0% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -36.3% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $2.64 million in FY2024 (-63.6%), $7.27 million in FY2023 (-71.6%), $25.58 million in FY2022 (-30.6%) and $36.89 million in FY2021 (-11.7%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development rose in five of the last six quarters, with growth averaging 56.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 212.1% in Q4 2025, against a decline of 31.3% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.08 million (Q1 2026), $1.47 million (Q4 2025) and $1.04 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | BeyondSpring | 25.75 Mn | 19.22 Mn | - | 973,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 973,000.00 |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 874,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | 622,000.00 |
| Jun 30, 2024 | 829,000.00 |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 8.46 Mn |
| Jun 30, 2021 | 11.33 Mn |
| Mar 31, 2021 | 11.31 Mn |
| Dec 31, 2020 | 8.42 Mn |
| Sep 30, 2020 | 8.64 Mn |
| Jun 30, 2020 | 11.03 Mn |
| Mar 31, 2020 | 13.70 Mn |
| Dec 31, 2019 | 12.58 Mn |
| Sep 30, 2019 | 7.23 Mn |
BeyondSpring Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BYSI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BYSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BYSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();